Prenatally diagnosed omphalocele: characteristics associated with adverse neonatal outcomes.


Journal

Journal of perinatology : official journal of the California Perinatal Association
ISSN: 1476-5543
Titre abrégé: J Perinatol
Pays: United States
ID NLM: 8501884

Informations de publication

Date de publication:
Aug 2019
Historique:
received: 25 01 2019
accepted: 20 05 2019
revised: 13 05 2019
pubmed: 23 6 2019
medline: 30 5 2020
entrez: 23 6 2019
Statut: ppublish

Résumé

To characterize factors associated with adverse neonatal outcomes in prenatally diagnosed omphalocele cases. Prenatally diagnosed omphalocele cases at a single referral center from 1 January 2009 to 31 December 2017 were retrospectively reviewed. Clinical variables and antenatal imaging measurements were collected. Associations between prenatal and neonatal characteristics and the adverse outcome of death or prolonged length of stay (LOS) were analyzed. Out of 63 fetal cases, 33 were live-born, > 50% had other anomalies, and neonatal mortality was 12%. Adverse outcomes were associated with neonatal variables, including lower median 1-min Apgar score, initial mechanical ventilation, and late-onset sepsis, but not approach to omphalocele closure. With multivariate analysis, death or prolonged LOS was associated only with low lung volumes by fetal MRI (OR 34 (3-422), p = 0.006). Low lung volumes by fetal MRI were associated with death or prolonged LOS in neonates with prenatally diagnosed omphalocele and may guide clinicians with counseling families.

Identifiants

pubmed: 31227786
doi: 10.1038/s41372-019-0410-1
pii: 10.1038/s41372-019-0410-1
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1111-1117

Auteurs

Valerie Y Chock (VY)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA. vchock@stanford.edu.
Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA. vchock@stanford.edu.

Alexis S Davis (AS)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.

Seo-Ho Cho (SH)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Stanford Prevention Research Center, Palo Alto, CA, 94305, USA.

Christina Bax (C)

Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, 19104, USA.

Elizabeth Fluharty (E)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.

Nicole Weigel (N)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.

Margaret Homeyer (M)

Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Division of Medical Genetics, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Louanne Hudgins (L)

Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Division of Medical Genetics, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Richard Jones (R)

Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Erika Rubesova (E)

Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Department of Radiology, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Karl G Sylvester (KG)

Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Department of Pediatric Surgery, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Yair J Blumenfeld (YJ)

Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.
Department of Obstetrics and Gynecology, Maternal Fetal Medicine, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.

Susan R Hintz (SR)

Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Palo Alto, CA, 94304, USA.
Fetal and Pregnancy Health Program, Lucile Packard Children's Hospital Stanford, Palo Alto, CA, 94304, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH